tradingkey.logo
tradingkey.logo
Search

Cardinal Health Inc

CAH
Add to Watchlist
227.501USD
+1.521+0.67%
Market hours ETQuotes delayed by 15 min
53.46BMarket Cap
34.64P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-23
Previous score
8.53
Change
0
The current earnings forecast score of Cardinal Health Inc is 8.53, ranking 31 out of 155 in the Pharmaceuticals industry. The average price target is 220.00, with a high of 243.00 and a low of 152.11.

Analyst Rating

Based on 19 analysts
Buy
Current Rating
254.082
Target Price
+11.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Cardinal Health Inc
CAH
19
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Cardinal Health Inc's expected revenue for the next quarter?

Cardinal Health Inc's expected revenue is 65.03B.

What is Cardinal Health Inc's price target?

Analysts forecast that Cardinal Health Inc's price target is USD 220.00, with the highest forecast at USD 243.00 and the lowest forecast at USD 152.11.

How have Cardinal Health IncCAH's recent earnings per share performed?

The market expectation was USD 1.70, while Cardinal Health IncCAH's earnings per share (EPS) for the previous quarter was USD 1.98. EPS for the next quarter is expected at USD 2.42.

What is the analyst rating for Cardinal Health Inc?

Based on the ratings of Cardinal Health Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.